| > You’re seeing neural and auto immune clusters gathering around certain immune dysfunction and previously rare diagnosis like Small Fiber Neuropathy. Everything I've personally seen in this space is exactly what I described: they start with a set of people who claim to have the illness, then go on a statistical fishing expedition to look for "signs of immune disfunction" (or whatever, but you're right that these researchers tend to focus on immune-related metrics), then use whatever signals they happen to find to create a class. This is not the same thing as what I'm talking about, and it isn't valid. I'm not going to claim comprehensive knowledge of the space, but the papers I've read that make it into the high-profile journals are of this sort. The papers cited by this Lowe article are better than most at least in the sense that they have control groups and are doing experiments. But let's be clear -- the first one is claiming to see "long covid" pain symptoms in mice who are injected with whole human IgG (a notoriously messy and subjective approach) [1], and the other is exactly the kind of fishing expedition I'm describing, where they indiscriminately look for "targets" of said antibodies [2]. The former is at least doing an experiment that I suppose could lead to some kind of claim of cause, but the latter (despite the exaggerated title) provides no evidence that the correlations they're seeing are meaningful in any disease process. I guarantee that using the high-dimensional screening that the latter paper in particular is doing, I can take 1000 random people, split them into two arbitrary classes ("fooists" and "non-fooists"), and find some "statistically significant" difference in immune marker profile between them. That is the fundamental problem with the approach. When I say that you have to start from an objective measurement of symptoms, it means literally that -- not starting from an assay result that is unlinked to any symptom. [1] https://www.sciencedirect.com/science/article/pii/S266637912... [2] https://www.sciencedirect.com/science/article/abs/pii/S00928... Aside: this lab is becoming infamous for this kind of statistical fishing expedition. It makes me cry for the state of science. |
There are two fairly strong clusters of findings that are objective, repeatable, and consistent. And that is the autonomic testing in long COVID patients is coherent in its dysfunction, and so is the Small Fiber Neuropathy testing that is now consistently showing abnormalities.
Lets go step by step.
Small Fiber Neuropathy. Nerve fiber density is a count with age/sex-normed reference ranges. In previously healthy post-COVID patients with no diabetes and no risk factor, then the test shows whether the nerves are there or they aren't.
https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1284&c...
https://www.medrxiv.org/content/10.1101/2025.03.04.25323101v...
https://www.neurology.org/doi/pdf/10.1212/NXI.00000000002002...
https://pmc.ncbi.nlm.nih.gov/articles/PMC12847426/pdf/fnhum-...
We have brain structure changes showing in the UK Biobank studies https://pmc.ncbi.nlm.nih.gov/articles/PMC9046077/
Associations with complement dysregulation https://www.cell.com/med/fulltext/S2666-6340(24)00041-2
Muscular abnormalities in long COVID patients reporting reduced exercise function https://www.sciencedirect.com/science/article/pii/S104327602...
Potential that persistent infection shows up in Long Covid patients in abnormal rates https://www.massgeneralbrigham.org/en/about/newsroom/press-r...
If your argument is that people are showing up with abnormalities, then diagnosed with Long Covid, then spurious biomarkers are associated to it - you are just wrong. Wrong multiple times. Demonstrably so.
What we are seeing is more likely to be exactly what it looks like - an novel condition being captured by downstream effects of previously unknown or understudied mechanisms.